Skip to main content
. 2020 Mar 11;6(1):35. doi: 10.3390/jof6010035
ART Antiretroviral therapy
BCG Bacillus Calmette–Guérin
CAGTA C. albicans germ tube antibodies
DABCO 1,4-Diazabicyclo[2.2.2]octane
DRF Damage response framework
DS Denture stomatitis
DSC Deep-seated candidiasis
GI Gastrointestinal
HDC Hematogenously disseminated candidiasis
HIV Human immunodeficiency virus
HS Heparan sulfate
HSPC Hematopoietic stem and progenitor cell
IAC Intra-abdominal candidiasis
IAI Intra-abdominal infection
ICU Intensive care unit
IFN Interferon
IL Interleukin
MDSC Myeloid-derived suppressor cell
NAC Non-albicans Candida
NSAID Non-steroidal anti-inflammatory drug
nTh17 Natural T helper type 17
OPC Oropharyngeal candidiasis
PDI Photodynamic inactivation
PMN Polymorphonuclear neutrophil
RVVC Recurrent vulvovaginal candidiasis
SAP Secretory aspartyl proteinase
Th T helper
TII Trained innate immunity
TTI Trained tolerogenic immunity
VVC Vulvovaginal candidiasis